Frontlight ResearchEarly access
Trial site
Maine Eye Center
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration9 trials
- Diabetic eye disease3 trials
- Phase
- Phase 37 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche5 trials
- Janssen Research & Development, LLC2 trials
- 4D Molecular Therapeutics1 trial
- Annexon, Inc.1 trial
- Boehringer Ingelheim1 trial
- and 2 more
Running trials
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
Closed trials
Completed
Completed
Completed
Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
Completed
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Site data: ClinicalTrials.govUpdated 12 Nov 2026